Optimal Cutoffs of Obesity Measures in Relation to Cancer Risk in Postmenopausal Women in the Women's Health Initiative Study

Journal of Women's Health

Volumn 24, Issue 3, 2015, Pages 218-227

  Heo, Moonseong ^a   Kabat, Geoffrey C ^a   Strickler, Howard D ^a   Lin, Juan ^a   Hou, Lifang ^b   Stefanick, Marcia L ^c   Anderson, Garnet L ^d   Rohan, Thomas E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CLINICAL STUDY; COLON CANCER; COLORECTAL CANCER; ENDOMETRIUM CANCER; FEMALE; HORMONAL THERAPY; HUMAN; KIDNEY; LOW RISK PATIENT; LUNG CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEOPLASM; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; VALIDATION STUDY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; WEIGHT HEIGHT RATIO; WOMEN HEALTH INITIATIVE; WOMEN'S HEALTH; BREAST NEOPLASMS; CLINICAL TRIAL; COMPLICATION; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SOCIOECONOMICS; UNITED STATES;

AGED; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; WOMEN'S HEALTH;

EID: 84924749886     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2014.4977     Document Type: Article

References (44)

1. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003;348:1625-1638.
2. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-591.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-578.
4. Han TS, Lean MEJ. Anthropometric indices of obesity and regional distributions of fat depots. In: Bjorntorp P, ed. International Textbook of Obesity. Chichester, UK: John Wiley & Sons, 2001:51-65.
5. Heymsfield S, Lohman TG, Wang Z, Going SB. Human body composition. USA. Human Kinetics, 2005.
6. Hu FB. Obesity epidemiology. New York: Oxford University Press, 2008.
7. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis 1972; 25:329-343.
8. Heo M, Kabat GC, Gallagher D, Heymsfield SB, Rohan TE. Optimal scaling of weight and waist circumference to height for maximal association with DXA-measured total body fat mass by sex, age and race/ethnicity. Int J Obes (Lond) 2013;37:1154-1160.
9. Taylor RW, Keil D, Gold EJ, Williams SM, Goulding A. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr 1998;67:44-49.
10. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269.
11. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996;20:291-302.
12. Pischon T, Lahmann PH, Boeing H, et al.: Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-931.
13. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: Findings from the european prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2004;111:762-771.
14. National Heart, Lung, and Blood Institute, Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National heart, lung, and blood institute clinical guidelines on the identification, and treatment of overweight and obesity in adults: The Evidence Report. NIH publication No. 98-4083. Bethesda, MD: Department of Health and Human Services, National Institutes of Health,1998.
15. Ligibel JA, Strickler HD. Obesity and its impact on breast cancer: Tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book 2013;2013:52-59.
16. Pfeiffer RM, Park Y, Kreimer AR, et al. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: Derivation and validation from populationbased cohort studies. PLoS Med 2013;10:e1001492.
17. Morimoto LM, White E, Chen Z, et al. Obesity, body size, and risk of postmenopausal breast cancer: The Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-751.
18. Huang Z, Willett WC, Colditz GA, et al. Waist circumference, waist: hip ratio, and risk of breast cancer in the Nurses' Health Study. Am. J. Epidemiol 1999;150:1316-1324.
19. Chang SC, Lacey JV, Brinton LA, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiology Biomarkers Prev 2007;16:723-730.
20. Anderson G, Cummings S, Freedman LS, et al. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61-109.
21. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13:S107-S121.
22. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann. Epidemiol 2003;13:S5-17.
23. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women - The Women's Health Initiative cohort study. JAMA 2003;290:1331-1336.
24. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann. Epidemiol 2003;13:S122-S128.
25. Schoenfeld D. Partial residulas for the proportional hazards model. Biometrika 1982;69:51-55.
26. Faraggi D, Simon R. A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis. Stat Med 1996;15:2203-2213.
27. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using optimal cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-835.
28. Mazumdar M, Smith A, Bacik J. Methods for categorizing a prognostic variable in a multivariable setting. Stat Med 2003;22:559-571.
29. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000;56:337-344.
30. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE. Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 2013;132:1125-1132.
31. Kabat GC, Anderson ML, Heo M, et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2013;22:1353-1363.
32. Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S. Height and site-specific cancer risk: A cohort study of a Korean adult population. Am J Epidemiol 2009;170:53-64.
33. Kabat GC, Heo M, Miller AB, Rohan TE. Scaling of weight for height in relation to risk of cancer at different sites in a cohort of Canadian women. Am J Epidemiol 2013;177:93-101.
34. Yang Y, Dong JY, Sun KK, et al. Obesity and incidence of lung cancer: A meta-analysis. Int J Cancer 2013;132:1162-1169.
35. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998;3:49-61.
36. Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009;101:48-60.
37. Karageorgi S, Hankinson SE, Kraft P, De Vivo I. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses'Health Study cohort 1976-2004. Int J Cancer 2010;126:208-216.
38. Reeves GK, Beral V, Green J, Gathani T, Bull D, Million Women Study C. Hormonal therapy for menopause and breast-cancer risk by histological type: A cohort study and meta-analysis. Lancet Oncol 2006;7:910-918.
39. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485-491.
40. Heo M, Allison DB, Fontaine KR. Overweight, obesity, and colorectal cancer screening: Disparity between men and women. BMC Public Health. 2004;4:53.
41. Fontaine KR, Heo M, Allison DB. Body weight and cancer screening among women. J Womens Health Gend Based Med 2001;10:463-470.
42. Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004;159:882-890.
43. Rohan TE, Heo M, Choi L, et al. Body fat and breast cancer risk in postmenopausal women: A longitudinal study. J Cancer Epidemiol 2013;2013:754815.
44. Kabat GC, Heo M, Wactawski-Wende J, et al. Body fat and risk of colorectal cancer among postmenopausal women. Cancer Causes Control 2013;24:1197-1205.